Sharda Cropchem Posts Strong Q1 FY27 Results: Revenue Grows 9% YoY, EBITDA Rises 25%

Sharda Cropchem Posts Strong Q1 FY27 Results: Revenue Grows 9% YoY, EBITDA Rises 25%​

Mumbai, July 29, 2026 - Sharda Cropchem Limited, a major player in the crop protection chemicals industry, has announced its unaudited financial results for the quarter ended June 30, 2026. The company reported significant improvements across key operating metrics, driven by expansion and product mix enhancements.

The consolidated highlights show robust growth in revenue and margins. Revenue grew by 9% year-on-year (YoY) to Rs. 1,074 crores. EBITDA saw a strong increase of 25%, reaching Rs. 178 crores, with the EBITDA margin improving by 220 basis points (bps) to 16.6%.

The consolidated financial performance for Q1 FY27 compared to Q1 FY26 is summarized below:

Segment and Product Performance Analysis​

The company’s portfolio is divided across Agrochemical and Non-Agro segments, with the former contributing 85% and the latter 15%.

In terms of product performance within the Agro segment, herbicides accounted for Rs. 457 crores (9% YoY), while insecticides generated Rs. 233 crores (13% YoY). Fungicides contributed Rs. 225 crores (2% YoY).

A breakdown of revenue by segment and product is provided in the tables below:

Segment Wise Revenue Break up (in Rs. Crs.)

Product Wise Revenue Break up (in Rs. Crs.)

Regional Business Highlights​

The company reported notable regional performance across both its agrochemical and non-agro businesses. The NAFTA region stood out for growth in both segments, while European markets moderated.

Agrochemical Region Wise Revenue Break up (in Rs. Crs.)

Non-Agrochemical Region Wise Revenue Break up (in Rs. Crs.)

Financial Health and Operations​

The company maintains a strong balance sheet. It is debt-free, holding cash, bank, and liquid investments totaling Rs. 767 crores. Product registrations have reached 3,016, with an additional 1,027 applications pending at various stages as of June 30, 2026. Capital expenditure (Capex) for Q1 FY27 stood at Rs. 263 crores.

Management Commentary​

Commenting on the results, Mr. Ramprakash Bubna, Chairman and MD, stated that the company delivered a strong start to FY27, marked by healthy operational improvements. He highlighted that revenue grew 9% YoY, while gross margins expanded by 120 bps to 36.7%. EBITDA increased 25%, with margin improvement reaching 220 bps to 16.6%.

Mr. Bubna attributed the improved profitability primarily to a favorable product mix and robust growth in NAFTA and LATAM markets. Regarding Europe, he noted that the market saw temporary moderation following a very strong FY26 due to reduced re-stocking by distributors amidst heat wave and drought situations across central eastern Europe; however, agrochemical margins in Europe still improved.

The Chairman affirmed the company's commitment to its long-term growth platform, driven by sustained investments in its registration pipeline. He added that the company is guided to maintain a FY27 revenue growth of 10% to 15%, while noting that its balance sheet remains robust with a debt-free position and financial flexibility provided by cash, bank balances, and liquid investments totaling Rs. 767 crores.

SHARDACROP Stock Price Movement​

As of 2:37 PM, shares of Sharda Cropchem Limited are shedding value in live trading, currently slipping by 5.77% to trade at ₹826.40. The stock is experiencing significant activity today, with over 667,574 shares traded so far.